Cargando…
A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels
INTRODUCTION: Self-reported prediabetes and diabetes rates underestimate true prevalence, but mass laboratory screening is generally impractical for risk assessment and surveillance. We developed the Abnormal Glucose Risk Assessment-6 (AGRA-6) tool to address this problem. METHODS: Self-report data...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831788/ https://www.ncbi.nlm.nih.gov/pubmed/20158962 |
_version_ | 1782178266472251392 |
---|---|
author | He, Guozhong Sentell, Tetine Schillinger, Dean |
author_facet | He, Guozhong Sentell, Tetine Schillinger, Dean |
author_sort | He, Guozhong |
collection | PubMed |
description | INTRODUCTION: Self-reported prediabetes and diabetes rates underestimate true prevalence, but mass laboratory screening is generally impractical for risk assessment and surveillance. We developed the Abnormal Glucose Risk Assessment-6 (AGRA-6) tool to address this problem. METHODS: Self-report data were obtained from the 1,887 adults (18 years or older) in the National Health and Nutrition Examination Survey (NHANES) 2005-2006 with fasting plasma glucose and oral glucose tolerance tests. We created AGRA-6 models by using logistic regression. Performance was validated with NHANES 2005-2006 data by using leave-1-out cross-validation. Standard performance characteristics (sensitivity, specificity, predictive values, area under receiver-operating characteristic curves) were assessed, as was the potential efficiency of the models to reduce laboratory testing in screening efforts. RESULTS: Performance was good for all models under testing conditions. Use of the AGRA-6 in screening efforts could reduce laboratory testing by at least 30% when sensitivity is maximized and at least 52% when sensitivity and specificity are balanced. CONCLUSION: The AGRA-6 appears to be an effective, feasible tool that uses self-reported data compatible with the Behavioral Risk Factor Surveillance System to assess population-level prevalence, identify abnormal glucose levels, optimize screening efforts, and focus interventions to reduce the prevalence of abnormal glucose levels. |
format | Text |
id | pubmed-2831788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-28317882010-03-25 A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels He, Guozhong Sentell, Tetine Schillinger, Dean Prev Chronic Dis Original Research INTRODUCTION: Self-reported prediabetes and diabetes rates underestimate true prevalence, but mass laboratory screening is generally impractical for risk assessment and surveillance. We developed the Abnormal Glucose Risk Assessment-6 (AGRA-6) tool to address this problem. METHODS: Self-report data were obtained from the 1,887 adults (18 years or older) in the National Health and Nutrition Examination Survey (NHANES) 2005-2006 with fasting plasma glucose and oral glucose tolerance tests. We created AGRA-6 models by using logistic regression. Performance was validated with NHANES 2005-2006 data by using leave-1-out cross-validation. Standard performance characteristics (sensitivity, specificity, predictive values, area under receiver-operating characteristic curves) were assessed, as was the potential efficiency of the models to reduce laboratory testing in screening efforts. RESULTS: Performance was good for all models under testing conditions. Use of the AGRA-6 in screening efforts could reduce laboratory testing by at least 30% when sensitivity is maximized and at least 52% when sensitivity and specificity are balanced. CONCLUSION: The AGRA-6 appears to be an effective, feasible tool that uses self-reported data compatible with the Behavioral Risk Factor Surveillance System to assess population-level prevalence, identify abnormal glucose levels, optimize screening efforts, and focus interventions to reduce the prevalence of abnormal glucose levels. Centers for Disease Control and Prevention 2010-02-15 /pmc/articles/PMC2831788/ /pubmed/20158962 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Original Research He, Guozhong Sentell, Tetine Schillinger, Dean A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels |
title | A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels |
title_full | A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels |
title_fullStr | A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels |
title_full_unstemmed | A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels |
title_short | A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels |
title_sort | new public health tool for risk assessment of abnormal glucose levels |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831788/ https://www.ncbi.nlm.nih.gov/pubmed/20158962 |
work_keys_str_mv | AT heguozhong anewpublichealthtoolforriskassessmentofabnormalglucoselevels AT sentelltetine anewpublichealthtoolforriskassessmentofabnormalglucoselevels AT schillingerdean anewpublichealthtoolforriskassessmentofabnormalglucoselevels AT heguozhong newpublichealthtoolforriskassessmentofabnormalglucoselevels AT sentelltetine newpublichealthtoolforriskassessmentofabnormalglucoselevels AT schillingerdean newpublichealthtoolforriskassessmentofabnormalglucoselevels |